History and Mission

The OSI Pharmaceuticals Foundation was established in 2005 with the purpose of investing in our communities through employee volunteerism, the support of cancer and diabetes patients and their families, and the funding of science education.

OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by discovering, developing and commercializing high quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer and diabetes/obesity. The OSI Pharmaceuticals Foundation is "changing lives in our communities."

Trustees and Officers

Trustees
G. Morgan Browne, Chairman
President, Planting Fields Foundation
Former Chief Financial Officer, Cold Spring Harbor Laboratory

Colin Goddard, PhD
Chief Executive Officer
OSI Pharmaceuticals, Inc.

Linda E. Amper, PhD
Sr. Vice President, Human Resources
OSI Pharmaceuticals, Inc.

John P. White
Partner, Cooper & Dunham LLP

Officers
Ann McDermott-Kave, Director
OSI Pharmaceuticals Foundation

Joseph Talamo, Treasurer
Vice President and Corporate Controller
OSI Pharmaceuticals, Inc.

For donation requests click here.